Apelin, a promising target for type 2 diabetes treatment?

Isabelle Castan-laurell, Cédric Dray, Claude Knauf, Oxana Kunduzova, Philippe Valet

Open source

DOI: 10.1016/j.tem.2012.02.005
Published: 2012-05
Container: Trends in Endocrinology & Metabolism
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.tem.2012.02.005,
  title = {Apelin, a promising target for type 2 diabetes treatment?},
  author = {Isabelle Castan-laurell and Cédric Dray and Claude Knauf and Oxana Kunduzova and Philippe Valet},
  year = {2012},
  journal = {Trends in Endocrinology \&amp; Metabolism},
  doi = {10.1016/j.tem.2012.02.005},
  url = {https://doi.org/10.1016/j.tem.2012.02.005}
}

RIS

TY  - JOUR
TI  - Apelin, a promising target for type 2 diabetes treatment?
AU  - Isabelle Castan-laurell
AU  - Cédric Dray
AU  - Claude Knauf
AU  - Oxana Kunduzova
AU  - Philippe Valet
PY  - 2012
JO  - Trends in Endocrinology &amp; Metabolism
DO  - 10.1016/j.tem.2012.02.005
UR  - https://doi.org/10.1016/j.tem.2012.02.005
ER  -

APA

Castan-laurell, I., Dray, C., Knauf, C., Kunduzova, O., & Valet, P. (2012). Apelin, a promising target for type 2 diabetes treatment?. Trends in Endocrinology & Metabolism. https://doi.org/10.1016/j.tem.2012.02.005

Source records

crossref · retrieved 2026-09-27T01:15:20.044Z